Recent advancements in neuropharmacology have brought to light S-CE-123, a dopamine transporter inhibitor showing remarkable promise in cognitive enhancement. Its emergence alongside R-modafinil, a well-studied compound with a similar target, paves the way for a fascinating comparative study. This duo of compounds, entwined in the complex dance of brain chemistry, offers a glimpse into the …
Hydrafinil (Fluorenol) is an unregulated research chemical originally synthesized by Cephalon Pharmaceuticals (now owned by Teva) as a eugeroic (wakefulness-promoting agent). After its synthesis, fluorenol was one of several agents to be considered as a hypothetical successor to the popularized and FDA-approved drug, Provigil (Modafinil). Comparative data from animal trials indicated that fluorenol exhibited ~39% …
Nuvigil and Provigil are both drugs that were approved by the FDA for the treatment of excessive daytime sleepiness. Both drugs act as eugeroics and are considered “wakefulness-promoting agents” in that they are distinct from more potent, habit-forming psychostimulants (e.g. Adderall). Provigil was initially approved in the late 1990s to help treat narcolepsy. Although the drug …
Nuvigil (Armodafinil) is a medication that was developed to promote vigilance and is medically classified as a “eugeroic.” It is very similar to the drug Provigil (Modafinil), but differs in that it only contains the R-stereoisomer of Modafinil. In other words, it is considered an improved version of the older drug Provigil. It was originally …